Dare Bioscience, Inc. (DARE) Operating cash flow 2016–2025
Dare Bioscience, Inc. (DARE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.9MFY2025 · since FY2016: -$372,299 → -$9.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.9M | -280.6% |
| FY2024 | $5.5M | +114.1% |
| FY2023 | -$38.9M | -114.8% |
| FY2022 | -$18.1M | +37.1% |
| FY2021 | -$28.8M | -14.0% |
| FY2020 | -$25.2M | -89.5% |
| FY2019 | -$13.3M | -29.7% |
| FY2018 | -$10.3M | -304.2% |
| FY2017 | -$2.5M | -582.3% |
| FY2016 | -$372,299 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DARE financial trends
DARE RevenueDARE Net incomeDARE Net marginDARE Gross profitDARE Gross marginDARE Operating incomeDARE Operating marginDARE Free cash flowDARE Capital expendituresDARE Return on equityDARE Stock buybacksDARE Dividends paidDARE Total assetsDARE Total liabilitiesDARE Shareholders’ equityDARE overview →